Overview

Heart Function in Rheumatoid Arthritis and Ankylosing Spondylitis Pre and Post-TNF Blocker

Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine possible alterations in cardiac function in patients with Rheumatoid Arthritis and Ankylosing Spondylitis under anti-TNF therapy, without clinical heart disfunction at baseline, using highly sensitive non-invasive methods.
Phase:
Phase 4
Details
Lead Sponsor:
University of Sao Paulo
Treatments:
Adalimumab
Etanercept
Infliximab
Natriuretic Peptide, Brain
Tumor Necrosis Factor Inhibitors